Drug news
Plethora/Schiele files PSD 502 at EMA for treatment of Premature Ejaculation
Plethora Solutions (a subsidiary of Sciele Pharma, a Shionogi company) has submitted a dossier to the European Medicines Agency (EMA) for the approval of PSD 502 for the treatment of Premature Ejaculation
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.